Your browser doesn't support javascript.
loading
Delivery of nano-emulgel carrier: optimization, evaluation and in vivo anti-inflammation estimations for osteoarthritis.
Shah, Kamal; Dewangan, Hitesh Kumar.
Afiliación
  • Rajni; University Institute of Pharma Sciences (UIPS), Chandigarh University NH-5, Chandigarh Ludhiana Highway, Mohali, 140413, Punjab (India).
  • Shah K; Institute of Pharmaceutical Research (IPR), GLA University, Mathura, NH-19, Mathura-Delhi Road P.O. Chaumuhan, 281406, Mathura (India).
  • Dewangan HK; University Institute of Pharma Sciences (UIPS), Chandigarh University NH-5, Chandigarh Ludhiana Highway, Mohali, 140413, Punjab (India).
Ther Deliv ; 15(3): 181-192, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38356357
ABSTRACT

Aim:

Optimization and evaluation of Aceclofenac nanoemulgel for treatment for rheumatoid arthritis and reduction of GI irritation and enhancement of bioavaibility. Materials &

methods:

Different batches of emulgel and selected batch was proceeded for characterization like particle size, scanning electron microscopy, drug ingredient, in vitro release, Fourier transform infrared and x-ray diffraction in vitro inflammation and gel evaluation such as (spreadability, swelling index), ex vitro permeation, skin irritation and in vivo anti-inflammatory.

Result:

Emulgel showed nanometri size sustained release (79.96% in 6 h), compatibility and anti-inflammatory activity compared with pure drug. Concluded that emulgels had better (nearly twice as good) anti-inflammatory action as the commercial product.

Conclusion:

Compared with the commercial gel, the emulgel's anti-inflammatory effect had a quicker onset and a longer duration of action.
A non-steroidal anti-inflammatory drug (NSAID) aceclofenac is used as the treatment for rheumatoid arthritis. It is generally taken orally. However, there are a few issues with it being taken this way. The main ones are some of the drug reacts too early in the body, meaning only a small amount of it reaches the parts of the body where it is needed; it can irritate the digestive system; and it does not dissolve very well in water, which also makes it harder to reach the parts of the body where it is needed. The authors of this study created a new type of gel for people to rub into their skin, instead of taking a pill. They hoped that this would allow the drug to be absorbed more directly into the parts of the body where it was needed, without irritating the digestive system. They tested the gel to see how well it contained and released the drug, how well it absorbed into the skin, and whether it irritated the skin. They found that the gel contained and released the drug more effectively than similar gels which are already available and caused less irritation to the skin.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Osteoartritis / Antiinflamatorios no Esteroideos Límite: Humans Idioma: En Revista: Ther Deliv Año: 2024 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Osteoartritis / Antiinflamatorios no Esteroideos Límite: Humans Idioma: En Revista: Ther Deliv Año: 2024 Tipo del documento: Article Pais de publicación: Reino Unido